Author: Adnkronos (Adnkronos )

(Adnkronos) – GAITHERSBURG, Md., Aug. 22, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate studies. XBB sublineage variants are overwhelmingly...

(Adnkronos) – Nonprofit generic drug manufacturer building foundation for end-to-end quality management  BARCELONA, Spain, Aug. 22, 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced that Civica Rx (Civica) has adopted Veeva Vault LIMS to optimize quality control. Vault LIMS builds on Civica’s success with Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training and...

(Adnkronos) – ABU DHABI, UAE, Aug. 22, 2023 /PRNewswire/ — The COP28 UAE Presidency has announced an ambitious and inclusive two-week thematic program for the conference to deliver on four key goals alongside the negotiations process and as part of the critical Global Stocktake response.  Taking place at Expo City Dubai from 30 November to...

(Adnkronos) – ATLANTA, Aug. 22, 2023 /PRNewswire/ — VOLO Events Agency, a leading producer of live events and experiential marketing, has been named #1 fastest-growing privately held media company in America by Inc. Magazine. VOLO also ranked 72nd overall on the 2023 Inc. 5000 list, which recognizes the nation’s most successful and dynamic businesses.  “We...

(Adnkronos) – Jon Leather appointed as head of European Supply Chain Defence advisory  LONDON, Aug. 22, 2023 /PRNewswire/ — BlueVoyant, a cyber security company that illuminates, validates, and remediates internal and external risks, announced today that industry specialist Jon Leather has joined the company as the Head of European Supply Chain Defence Advisory, further strengthening...

(Adnkronos) – ‘Topical Therapy for Treating the Wounds and Lesions on the Entire Skin Surface’  MT PLEASANT, S.C., Aug. 22, 2023 /PRNewswire/ — Paradigm Therapeutics Inc., a biopharmaceutical company, today announced the completion of the acquisition of the worldwide rights of SD-101, a topical whole-body treatment for all subtypes of Epidermolysis Bullosa (EB), from Amicus Therapeutics....

(Adnkronos) – “Terapia topica per il trattamento di ferite e lesioni sull’intera superficie cutanea”   MT PLEASANT, S.C., 22 agosto 2023 /PRNewswire/ — Paradigm Therapeutics Inc., azienda biofarmaceutica, ha annunciato oggi il completamento dell’acquisizione dei diritti mondiali di SD-101, un trattamento topico per tutto il corpo per tutti i sottotipi di Epidermolysis Bullosa (EB), da Amicus...